AllianceBernstein’s Zymeworks ZYME Stock Holding History

AllianceBernstein’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.47M	Buy	55,896 +5,866	+12%	+$139K	﹤0.01%	2162
2025 Q4	$1.32M	Hold	50,030	–	–	﹤0.01%	2219
2025 Q3	$855K	Hold	50,030	–	–	﹤0.01%	2416
2025 Q2	$628K	Hold	50,030	–	–	﹤0.01%	2513
2025 Q1	$596K	Hold	50,030	–	–	﹤0.01%	2484
2024 Q4	$732K	Hold	50,030	–	–	﹤0.01%	2482
2024 Q3	$628K	Hold	50,030	–	–	﹤0.01%	2554
2024 Q2	$426K	Sell	50,030 -220	-0.4%	-$1.96K	﹤0.01%	2750
2024 Q1	$529K	Buy	50,250 +14,460	+40%	+$161K	﹤0.01%	2566
2023 Q4	$372K	Buy	35,790 +4,110	+13%	+$32.8K	﹤0.01%	2749
2023 Q3	$201K	Buy	31,680 +14,460	+84%	+$107K	﹤0.01%	2959
2023 Q2	$149K	Buy	+17,220	New	+$154K	﹤0.01%	3033

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AllianceBernstein's ZYME Position: Q1 2026 in Review

AllianceBernstein increased its Zymeworks (ZYME) stake by 12% in Q1 2026, buying an estimated $139K and bringing the position to 55,896 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2162.

AllianceBernstein first reported a position in ZYME in Q2 2023 and has held it in 12 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

AllianceBernstein held 55,896 shares of Zymeworks worth $1.47M as of Q1 2026.
AllianceBernstein bought 5,866 Zymeworks shares in Q1 2026, an estimated $139K.
Zymeworks made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2162 holding.
AllianceBernstein first reported a position in Zymeworks in Q2 2023 and has held it in 12 quarters since.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.